ePrivacy and GPDR Cookie Consent by TermsFeed Generator

ARIMIDEX

1MG TBL FLM 100

SÚKL code 0191321
Name of the product ARIMIDEX
_MA_MEDICATION_DETAIL_INFO_MED_NAME i ARIMIDEX
Supplement 1MG TBL FLM 100
Strenght 1MG
Pharmaceutical form Film-coated tablet
Package 100
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance ANASTROZOLE (ANASTROZOLUM)
ATC group L02BG03
ATC group name ANASTROZOL
Doping Antagonisté a modulátory hormonů (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/.

Marketing authorisation information

Registration Number 44/1296/97-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 30. 09. 2019
MA Holder AstraZeneca UK Limited, Cambridge
MA Holder country VELKÁ BRITÁNIE
Actual MA holder Laboratoires Juvisé Pharmaceuticals, Villeurbanne
Actual MA holder country FRANCIE

Back to list